137 related articles for article (PubMed ID: 36465031)
1. Multiple breast cancer liver metastases response to macrophage-delivered nanotherapy evaluated via a 3D continuum model.
Goodin DA; Chau E; Tiwari A; Godin B; Frieboes HB
Immunology; 2023 Jun; 169(2):132-140. PubMed ID: 36465031
[TBL] [Abstract][Full Text] [Related]
2. Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.
Leonard F; Curtis LT; Hamed AR; Zhang C; Chau E; Sieving D; Godin B; Frieboes HB
Cancer Immunol Immunother; 2020 May; 69(5):731-744. PubMed ID: 32036448
[TBL] [Abstract][Full Text] [Related]
3. Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions.
Leonard F; Curtis LT; Yesantharao P; Tanei T; Alexander JF; Wu M; Lowengrub J; Liu X; Ferrari M; Yokoi K; Frieboes HB; Godin B
Nanoscale; 2016 Jul; 8(25):12544-52. PubMed ID: 26818212
[TBL] [Abstract][Full Text] [Related]
4. Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.
Tanei T; Leonard F; Liu X; Alexander JF; Saito Y; Ferrari M; Godin B; Yokoi K
Cancer Res; 2016 Jan; 76(2):429-39. PubMed ID: 26744528
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel.
Leonard F; Curtis LT; Ware MJ; Nosrat T; Liu X; Yokoi K; Frieboes HB; Godin B
Front Immunol; 2017; 8():693. PubMed ID: 28670313
[TBL] [Abstract][Full Text] [Related]
6. Local Targeting of Lung-Tumor-Associated Macrophages with Pulmonary Delivery of a CSF-1R Inhibitor for the Treatment of Breast Cancer Lung Metastases.
Alhudaithi SS; Almuqbil RM; Zhang H; Bielski ER; Du W; Sunbul FS; Bos PD; da Rocha SRP
Mol Pharm; 2020 Dec; 17(12):4691-4703. PubMed ID: 33170724
[TBL] [Abstract][Full Text] [Related]
7. Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis.
Zou L; Imani S; Maghsoudloo M; Shasaltaneh MD; Gao L; Zhou J; Wen Q; Liu S; Zhang L; Chen G
Oncol Rep; 2020 Sep; 44(3):1075-1093. PubMed ID: 32705227
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.
Borsoi C; Leonard F; Lee Y; Zaid M; Elganainy D; Alexander JF; Kai M; Liu YT; Kang Y; Liu X; Koay EJ; Ferrari M; Godin B; Yokoi K
Cancer Lett; 2017 Sep; 403():296-304. PubMed ID: 28687352
[TBL] [Abstract][Full Text] [Related]
9. Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun.
Shao W; Li S; Li L; Lin K; Liu X; Wang H; Wang H; Wang D
Protein Cell; 2019 Mar; 10(3):161-177. PubMed ID: 29667003
[TBL] [Abstract][Full Text] [Related]
10. The role of surgical intervention for isolated breast cancer liver metastasis: Results of case-control study with comparison to medical treatment.
Wen J; Ye F; Xie F; Liu D; Huang L; Fang C; Zhong S; Ren L
Cancer Med; 2020 Jul; 9(13):4656-4666. PubMed ID: 32396284
[TBL] [Abstract][Full Text] [Related]
11. Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.
Rajeshkumar NV; Yabuuchi S; Pai SG; Tong Z; Hou S; Bateman S; Pierce DW; Heise C; Von Hoff DD; Maitra A; Hidalgo M
Br J Cancer; 2016 Aug; 115(4):442-53. PubMed ID: 27441498
[TBL] [Abstract][Full Text] [Related]
12. Evolving Role of Liver Resection in Selected Patients With Metastatic Breast Cancer.
Millen JA; Hofmann A; Mesquita-Neto JW; Rose J; Macedo FI
J Surg Res; 2021 Mar; 259():363-371. PubMed ID: 33189360
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation in the treatment of breast cancer liver metastases.
Illing R; Gillams A
Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):781-4. PubMed ID: 20829004
[TBL] [Abstract][Full Text] [Related]
14. Aggressive treatment for hepatic metastases from breast cancer: results from a single center.
Polistina F; Costantin G; Febbraro A; Robusto E; Ambrosino G
World J Surg; 2013 Jun; 37(6):1322-32. PubMed ID: 23474856
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic resection for breast cancer metastases: results and prognosis (65 cases)].
Pocard M; Pouillart P; Asselain B; Falcou MC; Salmon RJ
Ann Chir; 2001 Jun; 126(5):413-20. PubMed ID: 11447791
[TBL] [Abstract][Full Text] [Related]
16. The potential targets for metastases: a study on altered circular RNA profile in breast cancer liver metastases.
Lin X; Hong S; Chen J; Chen W; Wu Z
Epigenomics; 2019 Aug; 11(11):1237-1250. PubMed ID: 31293174
[No Abstract] [Full Text] [Related]
17. Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
Front Oncol; 2021; 11():670723. PubMed ID: 34046360
[TBL] [Abstract][Full Text] [Related]
18. Is liver resection justified for patients with hepatic metastases from breast cancer?
Adam R; Aloia T; Krissat J; Bralet MP; Paule B; Giacchetti S; Delvart V; Azoulay D; Bismuth H; Castaing D
Ann Surg; 2006 Dec; 244(6):897-907; discussion 907-8. PubMed ID: 17122615
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.
Chen QF; Huang T; Shen L; Wu P; Huang ZL; Li W
Mol Clin Oncol; 2019 Sep; 11(3):259-269. PubMed ID: 31396386
[TBL] [Abstract][Full Text] [Related]
20. Modeling of Nanotherapy Response as a Function of the Tumor Microenvironment: Focus on Liver Metastasis.
Frieboes HB; Raghavan S; Godin B
Front Bioeng Biotechnol; 2020; 8():1011. PubMed ID: 32974325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
